Drug prescription attitudes and behaviour of general practitioners A. EkedahlS. I. AnderssonA. Melander Pharmacoepidemiology and Prescription Pages: 381 - 387
Effect of captopril on myocardial β-adrenoceptor density and Giα-proteins in patients with mild to moderate heart failure due to dilated cardiomyopathy H. JakobT. EschenhagenH. Völker Pharmacodynamics Pages: 389 - 394
Natriuretic and diuretic effects of felodipine and hydrochlorothiazide after single and repeated doses B. HasselgrenP. Johansson Pharmacodynamics Pages: 395 - 400
Influence and interference of isosorbide dinitrate and food intake on superior mesenteric artery impedance in humans M. De BuyzereE. RietzschelM. Afschrift Pharmacodynamics Pages: 401 - 405
Identical efficacy of terbutaline multidose dry powder inhaler prior to and after 4 weeks of use by asthmatic patients R. A. L. M. Stallaert Pharmacodynamics Pages: 407 - 409
Acute effects of low dose nicotine gum on platelet function in non-smoking hypertensive and normotensive men H. H. MundalK. GjesdalP. Hjemdahl Pharmacodynamics Pages: 411 - 416
Upper limit of plasma alanine amino transferase during Phase I studies M. SibilleB. BoutouyrieD. Vital Durand Clinical Trials Pages: 417 - 421
A population and family study of CYP1A2 using caffeine urinary metabolites A. CatteauN. PoissonP. R. Bechtel Pharmacokinetics and Disposition Pages: 423 - 430
Induction of cytochrome P4501A by smoking or omeprazole in comparison with UDP-glucuronosyltransferase in biopsies of human duodenal mucosa J. BuchthalA. BuchmannP. Beaune Pharmacokinetics and Disposition Pages: 431 - 435
Clinical pharmacological equivalence of a novel FCH-free GTN spray with low ethanol content vs a FCH-containing GTN spray C. de MeyK. ErbH. Blume Pharmacokinetics and Disposition Pages: 437 - 443
CSF concentrations and clinical effects following intravenous dixyrazine premedication M. OikkonenJ. KärkeläT. Seppälä Pharmacokinetics and Disposition Pages: 445 - 447
Variable activation of lovastatin by hydrolytic enzymes in human plasma and liver B.-K. TangW. Kalow Pharmacokinetics and Disposition Pages: 449 - 451
Whole-blood pharmacokinetics and metabolic effects of the topical carbonic anhydrase inhibitor dorzolamide J. BiollazA. MunafoF. Brunner-Ferber Pharmacokinetics and Disposition Pages: 453 - 460
Serum sex hormone levels after replacing carbamazepine with oxcarbazepine J. I. T. IsojärviV. V. MyllyläO. Pelkonen Pharmacokinetics and Disposition Pages: 461 - 464
The protective effect of transdermal broxaterol on exercise-induced bronchoconstriction M. RobuschiM. ScuriR. Pisati Letter to the Editors Pages: 465 - 466